Table 4.
Effects of PP, PE, PB, and PW on liver fibrosis indexes (mean ± SD, n = 3).
| Group | Dose (μg·mL−1) | LN (μg·L−1) | HA (ng·L−1) | PCIII (μg·L−1) |
|---|---|---|---|---|
| Blank control | 0 | 51.8 ± 0.78 | 26.9 ± 5.67 | 18.8 ± 4.53 |
| BJRG | 50 | 211.0 ± 5.08∗∗ | 64.5 ± 3.19∗ | 29.2 ± 2.53∗∗ |
| Model group (TGF-β1) | 0.1 | 833.4 ± 9.94## | 302.3 ± 7.44## | 115.3 ± 3.38## |
| PW | 75 | 638.27 ± 7.22#ΔΔ | 178.82 ± 3.94#∗Δ | 108.87 ± 9.29##ΔΔ |
| PB | 75 | 502.56 ± 5.85#∗ΔΔ | 111.37 ± 4.95#∗Δ | 78.36 ± 5.22#Δ |
| PE | 75 | 118.40 ± 5.74∗∗ | 70.80 ± 7.07∗ | 28.30 ± 0.21∗∗ |
| PP | 75 | 97.32 ± 6.30∗∗ | 30.91 ± 5.22∗∗ | 19.01 ± 4.26∗∗ |
Compared with the blank control group (#P < 0.05, ##P < 0.01); compared with the model group (∗P < 0.05, ∗∗P < 0.01); compared with the PP group, (ΔP < 0.05, ΔΔP < 0.01).